Andrew Littlehale

Andrew Littlehale has a strong background in finance, holding various leadership positions in the biotechnology and pharmaceutical industries. Andrew most recently served as the Vice President Finance at Orionis Biosciences since October 2018. Prior to that, they were the Chief Financial Officer at Macrolide Pharmaceuticals from March 2016 to September 2018. Andrew also held the position of EVP Finance at Synlogic, Inc. from February 2015 to March 2016. From July 2010 to January 2015, they served as the Vice President of Finance at FORMA Therapeutics. Earlier in their career, they were the VP of Finance & Administration at Aeris Therapeutics from April 2005 to July 2010 and the Controller at Genomics Collaborative from 2000 to 2004.

Andrew Littlehale attended Wheaton College from 1992 to 1996, where they earned a Bachelor of Arts degree. Andrew then went on to pursue further education at Suffolk University's Sawyer Business School from 2005 to 2007, where they obtained a Master of Business Administration (MBA) degree.